Peter García
Director of Finance/CFO at ALX ONCOLOGY HOLDINGS INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Peter S.
García is currently serving as an Independent Director at DURECT Corp., a Director at Moraga Biotechnology Corp., a Director at Noden Pharma USA, Inc., and the Chief Financial Officer at ALX Oncology Holdings, Inc. He started his current position at ALX Oncology Holdings, Inc. in 2020.
In his former roles, Mr. García worked as a Principal at Amgen, Inc. from 1990 to 1996.
He also served as the Chief Financial Officer & Secretary at MDRNA, Inc. in 2010, the CFO, Head-Investor & Media Relations at Lineage Cell Therapeutics, Inc. from 2011 to 2013, the Chief Financial Officer & Senior Vice President at Nuvelo, Inc. from 2001 to 2004, the Chief Financial Officer at IntraBiotics Pharmaceuticals, Inc. from 1996 to 2004, the Chief Financial Officer at Dendreon Corp.
from 1996 to 2004, the Chief Financial Officer at CYTYC Surgical Products, the Chief Financial Officer at Nanosys, Inc. from 2004 to 2008, the Chief Financial Officer at Asterias Biotherapeutics, Inc., and a Principal at Teradata Corp.
Mr. García's education includes an undergraduate degree from Stanford University in 1983 and an MBA from the University of California, Los Angeles in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-13 | 110,348 ( 0.22% ) | 1 M $ | 2024-03-30 | |
DURECT CORPORATION
0.02% | 2024-03-25 | 7,000 ( 0.02% ) | 8 470 $ | 2024-03-30 |
Peter García active positions
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director of Finance/CFO | 2019-12-31 |
| DURECT CORPORATION | Director/Board Member | 2021-12-12 |
Noden Pharma USA, Inc.
 Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | Director/Board Member | - |
| Moraga Biotechnology Corp. | Director/Board Member | 2011-05-10 |
Former positions of Peter García
| Companies | Position | End |
|---|---|---|
| PDL BIOPHARMA, INC. | Director of Finance/CFO | 2019-08-14 |
| LINEAGE CELL THERAPEUTICS, INC. | Director of Finance/CFO | 2013-05-09 |
| ADHERA THERAPEUTICS, INC. | Director of Finance/CFO | 2011-09-07 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Director of Finance/CFO | 2010-07-21 |
Nanosys, Inc.
 Nanosys, Inc. Chemicals: SpecialtyProcess Industries Nanosys, Inc. develops and manufactures inorganic nanostructures and other related products. It offers Ultra HD television. The company was founded by Paul A. Alivisatos, Stephen Empedocles, Peidong Yang, Robert M. Metcalfe, Jim Heath, Paul McEuen, Christoph H. Westphal, Moungi Bawendi, Lawrence A. Bock, Calvin Y. H. Chow, Chunming Niu, Karen Vergura, Hongkun Park, George Pontis and Charles M. Lieber in 2001 and is headquartered in Milpitas, CA. | Director of Finance/CFO | 2007-12-31 |
Training of Peter García
| Stanford University | Undergraduate Degree |
| University of California, Los Angeles | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| AMGEN INC. | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| DURECT CORPORATION | Health Technology |
| TERADATA CORPORATION | Technology Services |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 11 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
| Nuvelo, Inc. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
CYTYC Surgical Products
 CYTYC Surgical Products Pharmaceuticals: MajorHealth Technology CYTYC Surgical Products was founded to design, develop, manufacture and market innovative therapeutic devices that improve the quality of women's healthcare in a cost- effective manner. Its initial product, the Novasure Endometrial Ablation System, is used to treat women who suffer from excessive menstrual bleeding. | Health Technology |
Nanosys, Inc.
Nanosys, Inc. Chemicals: SpecialtyProcess Industries Nanosys, Inc. develops and manufactures inorganic nanostructures and other related products. It offers Ultra HD television. The company was founded by Paul A. Alivisatos, Stephen Empedocles, Peidong Yang, Robert M. Metcalfe, Jim Heath, Paul McEuen, Christoph H. Westphal, Moungi Bawendi, Lawrence A. Bock, Calvin Y. H. Chow, Chunming Niu, Karen Vergura, Hongkun Park, George Pontis and Charles M. Lieber in 2001 and is headquartered in Milpitas, CA. | Process Industries |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Noden Pharma USA, Inc.
Noden Pharma USA, Inc. Electronic Equipment/InstrumentsElectronic Technology Noden Pharma USA, Inc. is engaged in manufacturing and commercialization of filled and finished medicine products. The company is headquartered in Orlando, FL. | Electronic Technology |
| Novacept, Inc. | |
| Moraga Biotechnology Corp. |
- Stock Market
- Insiders
- Peter García
